Magnetic Resonance Spectroscopy: Principles and Techniques: Lessons for Clinicians

Journal of Clinical and Experimental Hepatology

Volumn 5, Issue 4, 2015, Pages 320-328

  Tognarelli, Joshua M ^a   Dawood, Mahvish ^a   Shariff, Mohamed I F ^a   Grover, Vijay P B ^a   Crossey, Mary M E ^a   Cox, I Jane ^b   Taylor Robinson, Simon D ^a   McPhail, Mark J W ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF HEPATOLOGY   (United Kingdom)

Author keywords

Magnetic resonance imaging; Magnetic resonance spectroscopy; Metabolomics; Nuclear magnetic resonance

Indexed keywords

CHOLINE; CREATINE; DRUG METABOLITE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; LACTIC ACID; N ACETYLASPARTIC ACID; PROTON; TRIMETHYLAMINE OXIDE;

AGE; ALCOHOL CONSUMPTION; BODY MASS; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; DATA ANALYSIS; DIET; DIET RESTRICTION; DISCRIMINANT ANALYSIS; ELECTROMAGNETIC RADIATION; EXERCISE; FLUORINE NUCLEAR MAGNETIC RESONANCE; INFORMATION PROCESSING; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; MAGNETIC FIELD; MASS SPECTROMETRY; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; METABOLISM; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTIAL LEAST SQUARES REGRESSION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOFREQUENCY; REPRODUCIBILITY; REVIEW; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SMOKING; STRESS;

EID: 84949309906     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/j.jceh.2015.10.006     Document Type: Review

References (54)

1. Radda G.K., Rajagopalan B., Taylor D.J. Biochemistry in vivo: an appraisal of clinical magnetic resonance spectroscopy. Magn Reson Q 1989, 5:122-151.
2. Cox I.J. Development and applications of in vivo clinical magnetic resonance spectroscopy. Prog Biophys Mol Biol 1996, 65:45-81.
3. Harwood L.M., Moody C.J., Percy J.M. Experimental Organic Chemistry 2003, Blackwell Science Limited, UK.
4. Higson S.P. Analytical Chemistry 2004, Oxford University Press, Oxford.
5. Rouessac F., Rouessac A. Chemical Analysis Modern Instrumentation Methods and Techniques 2000, John Wiley & Sons Limited, Chichester.
6. Bottomley P.A. The trouble with spectroscopy papers. J Magn Reson Imaging 1992, 2(1):1-8.
7. 1H-MRS in vivo at 1.5 Tesla: validation by gas chromatography. NMR Biomed 2010, 23(5):466-472.
8. Matthaei D., Frahm J., Haase A., Merboldt K.D., Hanicke W. Multipurpose NMR imaging using stimulated echoes. Magn Reson Med 1986, 3(4):554-561.
9. Bottomley P.A. Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 1987, 508:333-348.
10. Klose U. Measurement sequences for single voxel proton MR spectroscopy. Eur J Radiol 2008, 67(2):194-201.
11. Herrmann T., Guntert P., Wuthrich K. Protein NMR structure determination with automated NOE-identification in the NOESY spectra using the new software ATNOS. J Biomol NMR 2002, 24(3):171-189.
12. Van Q.N., Chmurny G.N., Veenstra T.D. The depletion of protein signals in metabonomics analysis with the WET-CPMG pulse sequence. Biochem Biophys Res Commun 2003, 301(4):952-959.
13. Keevil S.F., Barbiroli B., Brooks J.C., et al. Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain. Magn Reson Imaging 1998, 16(9):1093-1106.
14. Gadian D.G. NMR and its Applications to Living Systems 1995, Oxford University Press, Oxford. 2nd ed.
15. 31P MR spectra. NMR Biomed 2003, 16(3):168-176.
16. 1H-magnetic resonance spectroscopy and a gallery of artifacts. NMR Biomed 2004, 17(6):361-381.
17. Vanhamme L., van den Boogaart A., Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997, 129(1):35-43.
18. 31P-magnetic resonance spectroscopy studies of nucleated and non-nucleated erythrocytes; time domain data analysis (VARPRO) incorporating prior knowledge can give information on the binding of ADP. Biochim Biophys Acta 1996, 1291(2):143-148.
19. Nicholson J.K., Lindon J.C. Systems biology: metabonomics. Nature 2008, 455(7216):1054-1056.
20. Fiehn O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp Funct Genomics 2001, 2(3):155-168.
21. Want E.J., Cravatt B.F., Siuzdak G. The expanding role of mass spectrometry in metabolite profiling and characterization. Chembiochem 2005, 6(11):1941-1951.
22. Want E.J., Nordstrom A., Morita H., Siuzdak G. From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. J Proteome Res 2007, 6(2):459-468.
23. 1H NMR spectroscopy characterisation of the complex metabolic pattern of urine from patients with inborn errors of metabolism: 2-hydroxyglutaric aciduria and maple syrup urine disease. J Pharm Biomed Anal 1997, 15(11):1647-1659.
24. 13C NMR spectroscopy of human blood plasma. Anal Chem 1995, 67(5):793-811.
25. Wishart D.S., Tzur D., Knox C., et al. HMDB: the Human Metabolome Database. Nucleic Acids Res 2007, 35(Database issue):D521-D526.
26. Holmes E., Loo R.L., Stamler J., et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 2008, 453(7193):396-400.
27. Williams H.R., Cox I.J., Walker D.G., et al. Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol 2009, 104(6):1435-1444.
28. Bertini I., Calabro A., De C., et al. The metabonomic signature of celiac disease. J Proteome Res 2009, 8(1):170-177.
29. Gao H., Dong B., Liu X., Xuan H., Huang Y., Lin D. Metabonomic profiling of renal cell carcinoma: high-resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysis. Anal Chim Acta 2008, 624(2):269-277.
30. 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis. Cancer Sci 2009, 100(4):782-785.
31. Khan S.A., Cox I.J., Thillainayagam A.V., Bansi D.S., Thomas H.C., Taylor-Robinson S.D. Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer. Eur J Gastroenterol Hepatol 2005, 17(7):733-738.
32. 1H NMR spectroscopy in conjunction with multivariate data analysis. J Proteome Res 2008, 6(7):2605-2614.
33. Trygg J., Holmes E., Lundstedt T. Chemometrics in metabonomics. J Proteome Res 2007, 6(2):469-479.
34. Jolliffe I. Principal component analysis. Wiley StatsRef: Statistics Reference Online 2015, John Wiley and Sons, New York, Onlinelibrary.wiley.com/doi/10.1002/9781118445112.stat06472/abstract (accessed 26 August).
35. Haenlein M., Kaplan A.M. A beginner's guide to partial least squares analysis. Understanding Statistics 2004, 3(4):283-297.
36. Bouatra S., Aziat F., Mandal R., et al. The human urine metabolome. PLoS One 2013, 8(9):e73076.
37. Ryan D., Robards K., Prenzler P.D., Kendall M. Recent and potential developments in the analysis of urine: a review. Anal Chim Acta 2011, 684(1-2). 8-20.
38. Patel N.R., McPhail M.J., ShariffM.I., Keun H.C., Taylor-Robinson S.D. Biofluid metabonomics using (1)H NMR spectroscopy: the road to biomarker discovery in gastroenterology and hepatology. Expert Rev Gastroenterol Hepatol 2012, 6(2):239-251.
39. Heather L.C., Wang X., West J.A., Griffin J.L. A practical guide to metabolomic profiling as a discovery tool for human heart disease. J Mol Cell Cardiol 2013, 55:2-11.
40. Dumas M.E., Kinross J., Nicholson J.K. Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease. Gastroenterology 2014, 146(1):46-62.
41. ShariffM.I.F. Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population. J Proteome Res 2010, 9(2):1096.
42. ShariffM.I., Gomaa A.I., Cox I.J., et al. Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study. J Proteome Res 2011, 10(4):1828-1836.
43. Ladep N.G., Dona A.C., Lewis M.R., et al. Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma (HCC) in West Africans. Hepatology 2014, 60:1291-1301. 10.1002/hep.27264.
44. 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis. Cancer Sci 2009, 100(4):782.
45. Khan S.A., Cox I.J., Thillainayagam A.V., Bansi D.S., Thomas H.C., Taylor-Robinson S.D. Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer. Eur J Gastroenterol Hepatol 2005, 17:733-738.
46. Sands C.J., Guha I.N., Kyriakides M., et al. Metabolic phenotyping for enhanced mechanistic stratification of chronic hepatitis C-induced liver fibrosis. Am J Gastroenterol 2015, 110(January (1)):159-169.
47. 1H-NMR metabolomic fingerprints of acute-on-chronic liver failure in intensive care unit patients with alcoholic cirrhosis. PLoS One 2014, 9(February (2)):e89230. eCollection 2014. 10.1371/journal.pone.0089230.
48. Holmes E., Wijeyesekera A., Taylor-Robinson S.D., Nicholson J.K. The promise of metabolic phenotyping in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 2015, 12(August (8)):458-471. 10.1038/nrgastro.2015.114.
49. Menon D.K., Sargentoni J., Taylor-Robinson S.D., et al. Effect of functional grade and aetiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology 1995, 21:417-427.
50. 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver 1997, 17:198-209.
51. 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology 2003, 37:788-794.
52. Taylor-Robinson S.D., Sargentoni J., Bell J.D., et al. In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts. Gut 1998, 42:735-743.
53. Taylor-Robinson S.D., Sargentoni J., Mallalieu R.J., et al. Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy. Hepatology 1994, 20:1173-1178.
54. Forton D.M., Patel N., Prince M., et al. Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. Gut 2004, 53:587-592.